Search

Sanjay Malhotra lab at the OHSU Knight Cancer Institute

Sanjay Malhotra lab at the OHSU Knight Cancer Institute

July 05, 2024

Dhanir Tailor, Ph.D., left, Sanjay Malhotra, Ph.D., and Arpit Dheeraj, Ph.D., are among the developers of the first drug that targets YB-1, an important signaling point in many different cancers. The drug has shown powerful anti-tumor activity in animal models of several different tumor types. (OHSU/Christine Torres Hicks)

See More Stories